The International Caviar Market Is Rife with Fraud
Caviar has never gone out of style, but these days, it’s particularly in demand. In the last year or so, the upmarket delicacy has begun to make regular appearances in over-the-top stunt foods, such as garnishing fried fish sandwiches, and highbrow-lowbrow trendy pairings like caviar-topped Pringles. Market research suggests that U.S. sales are expected to surpass $400 million this year, up from $100 million in 2022.
[time-brightcove not-tgx=”true”]
This swelling demand may be good news for Pringles, but it’s bad news to Jutta Jahrl, a conservationist and project manager at the World Wildlife F...
Source: TIME: Health - November 22, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Source Type: news
What You Need to Know About Compounded Versions of Popular Weight Loss Drugs
With social media fueling the huge demand for drugs like Ozempic, Rybelsus, Wegovy, and Mounjaro, which are helping people to lose more weight than any previous weight loss medications, it’s no surprise that manufacturers have had trouble keeping up. And the recent approval of Eli Lilly’s Zepbound, which is the same drug, Mounjaro, approved already for diabetes, but renamed specifically for weight management, will only add to that demand. Novo Nordisk, which makes Ozempic, Wegovy, and Rybelsus, for example, has intentionally cut back on production of Wegovy in an effort to limit new prescriptions, to ensure tha...
Source: TIME: Health - November 20, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
More Free COVID-19 Tests Are Available for the Holiday Season
WASHINGTON — Americans can order more free COVID-19 tests online for home delivery.
The U.S. government is offering to send another round of four at-home virus tests ahead of the typical surge in cases during the winter holiday season.
Anyone who did not order a batch of four COVID-19 tests in September can secure up to eight of them this time around starting Monday at COVIDtests.gov. The U.S. Postal Service will deliver them for free.
[time-brightcove not-tgx=”true”]
The government is mailing out the coronavirus tests as the the flu season kicks off and a spike in RSV cases&...
Source: TIME: Health - November 20, 2023 Category: Consumer Health News Authors: AMANDA SEITZ / AP Tags: Uncategorized COVID-19 News Desk wire Source Type: news
The Epidemic of Violence in American Hospitals
On Friday, an individual allegedly entered the lobby of a state psychiatric hospital in Concord, New Hampshire killing a security guard. A state trooper on duty assigned to the facility subsequently shot and killed the gunmen.
[time-brightcove not-tgx=”true”]
In early September, a nurse at Inspira Medical Center in Vineland, New Jersey was nearly injured after a patient shot and killed himself, prompting a lockdown inside the hospital. The incident left healthcare workers, visitors, and patients filled with terror.
The ongoing and escalating violence in and around hospitals in the U.S. is a clear and pre...
Source: TIME: Health - November 20, 2023 Category: Consumer Health News Authors: Robert Glatter and Peter Papadakos Tags: Uncategorized freelance Source Type: news
Why the FDA Is Screening Cinnamon Imports for Lead
The Food and Drug Administration (FDA) is investigating cinnamon apple puree and applesauce products amid reports of elevated blood lead levels in at least 34 individuals.
Residents in more than 20 states have reported illness after exposure to cinnamon apple products offered by three brands: WanaBana, Weis, and Schnucks. The goods are manufactured in Ecuador and have since been recalled.
[time-brightcove not-tgx=”true”]
Recent screens by the FDA and other state partners found lead levels in at least one product nearly 200 times greater than those in FDA guidelines.
“FDA’s le...
Source: TIME: Health - November 17, 2023 Category: Consumer Health News Authors: Solcyre Burga Tags: Uncategorized News News Desk Source Type: news
How Drug Makers Manipulate Patents to Keep Insulin Prices High
The financial burden of high insulin costs that patients and insurers face is often blamed on the Food and Drug Administration’s (FDA) regulatory framework, but a new study suggests pharmaceutical companies have also been using patenting processes to unfairly maintain high costs. In the FDA’s master list of approved medications, devices, and other therapeutics, a document known as the Orange Book, patent ownership of each item governs which companies are allowed to manufacture and sell which therapies. The FDA deals with drug approval, but patents are granted by another agency entirely, the U.S. Patent and Trad...
Source: TIME: Health - November 17, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized Drugs healthscienceclimate Source Type: news
Your 2023 Holiday Season Guide to COVID-19, Flu, and RSV
As you make your shopping list, plan travel, and schedule parties this holiday season, there’s something else you should add to your to-do list: making sure you’re up-to-date on the latest guidance around COVID-19, the flu, and RSV, as respiratory disease season hits full swing.
“It’s always important to factor in the possibility of either transmitting an infection to other people or becoming infected, especially when getting together in large groups,” says Matthew Binnicker, director of clinical virology at the Mayo Clinic. “There are ways to safely gather and enjoy the holiday seaso...
Source: TIME: Health - November 16, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
CRISPR Therapy Gets U.K. Approval, the First in the World
Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.
[time-brightcove not-tgx=”true”]
In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020.
The agency approved the treatment for patients with sickle cell disease and thalassemia who are 12 years old and over. Casgevy is made by Vertex ...
Source: TIME: Health - November 16, 2023 Category: Consumer Health News Authors: MARIA CHENG / AP Tags: Uncategorized Drugs wire Source Type: news
Yes, You Can Get Better at Saying No
There’s a common malfunction that occurs when well-intentioned people open their mouths to say no: The word “yes” tumbles out instead.
We’ve all been there, says Vanessa Bohns, department chair and professor of organizational behavior at Cornell University. No is a deceptively short, simple word that can trigger several layers of anxiety for the person trying to say it. For starters: What does it reveal about our character? “We worry that we’re essentially communicating that we’re not a helpful person; we’re not a nice, kind person; we’re not a team player,” Bo...
Source: TIME: Health - November 16, 2023 Category: Consumer Health News Authors: Angela Haupt Tags: Uncategorized healthscienceclimate Source Type: news
How to End the Futile Blame Game Over Failed Long COVID Research
The health outlook for Long COVID sufferers is no better today than it was when the condition was first recognized in early 2020. This has been attributed in large measure to the disappointing results of clinical research, particularly when compared to the magnitude of the problem.
[time-brightcove not-tgx=”true”]
Now with hundreds of published results emerging from federally conducted or sponsored research, outraged experts and patient advocates say that there is little to show for it. The critique is that the pace of the work is slow and opaque, and that little has emerged that directly impacts prev...
Source: TIME: Health - November 15, 2023 Category: Consumer Health News Authors: Steven Phillips and Michelle Williams Tags: Uncategorized COVID-19 Source Type: news
Now Asia Is Facing a Bedbug Crisis
They’re a global nightmare. First they haunted Paris last month, before panic over potential outbreaks gripped Europe and the U.S. Now, bedbugs are terrifying a number of countries in Asia, where surges in infestations of the pest are fueling fresh anxieties among the public and stirring governments to action.
Read More: Bed Bugs Aren’t Just a Problem in Paris. Here’s Why
[time-brightcove not-tgx=”true”]
Since the start of November, South Korea has embarked on a fierce campaign against the bloodsucking critters. Bedbugs had been largely eradicated there during a national extermination d...
Source: TIME: Health - November 15, 2023 Category: Consumer Health News Authors: Koh Ewe Tags: Uncategorized News Desk Source Type: news
Why U.S. Women Now Live Almost 6 Years Longer Than Men
U.S. women are now projected to live about six years longer than U.S. men, as COVID-19 and drug overdoses claim more male than female lives, according to research published Nov. 13 in JAMA Internal Medicine.
Overall U.S. life expectancy has declined in recent years and, as of the latest estimate, sits at around 76 years. But as the new research details, women are expected to live significantly longer than men. As of 2021, the latest year with federal data available, life expectancy among U.S. men was 73.5 years, compared to 79.3 years among women.
[time-brightcove not-tgx=”true”]
Across the world, women ...
Source: TIME: Health - November 14, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
Rebound Infections Occur in 20% of Paxlovid Users, According to New Research
COVID-19 has become less of an urgent threat than it was in 2019 largely because of vaccines and growing immunity from natural infections, but antiviral treatments have also changed the course of the disease. The most popular of these is nirmatrelvir-ritonavir, sold under the brand name Paxlovid, which the U.S. Centers for Disease Control and Prevention (CDC) recommends for older people and anyone over age 12 who is at higher risk of COVID-19 complications. But people taking the drug have reported incomplete recovery, or testing positive again after testing negative once they finished the five-day course of the oral medica...
Source: TIME: Health - November 14, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
How Racism Affects the Mental Health of Black Youth
On Sept. 25, 2023, the Biden-Harris administration announced that it will be investing some $200 million in the youth mental health crisis. Since youth mental health was declared a national emergency in 2021, multiple experts, including the U.S. Surgeon General, have cited social media and the COVID-19 pandemic, among other things, as major contributing factors.
[time-brightcove not-tgx=”true”]
But what has not been talked about to the same extent, is how anti-Black racism is fueling the youth mental health crisis. Racism has a crucial impact on the mental health of ...
Source: TIME: Health - November 14, 2023 Category: Consumer Health News Authors: Amanda Joy Calhoun Tags: Uncategorized freelance Health Care Source Type: news
Weight Loss Drug Wegovy Can Also Reduce Risk of Serious Heart Events, Study Shows
Popular weight loss drugs have dominated news headlines and social media, mostly for their ability to help people shed pounds and control diabetes. But now there is evidence that one of the drugs, semaglutide, can also help reduce the risk of dying from heart disease in some patients. The drug semaglutide is sold under the brand names Wegovy, Ozempic, and Rybelsus. This trial, however, only studied the effects of Wegovy, which is semaglutide at 2.4mg in injectable form, and currently approved for weight management. The results of a much-anticipated study, sponsored by semaglutide’s maker Novo Nordisk, investigating t...
Source: TIME: Health - November 11, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
